ARCHIVES

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Tobacco Council Announces 11 New Grant Awards

January 24, 1975

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

In Brief: Hammond Honored By ACS; SEER Celebrates 20th Anniversary With Symposium Dec. 8

December 3, 1993

Senate Subcommittee Agrees On $1.188 Billion NCI Budgt for FY 1985, $110 Million Increase Over ‘84

June 29, 1984